ArticleJournal of clinical medicine2025

Real-Life Effectiveness and Safety of Bimekizumab in Plaque Psoriasis Involving Difficult-to-Treat Areas: A 52-Week, Retrospective Real-World, Single-Center Study.

Matteo Bianco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.